Suven Life Sciences announces first subjects dosed in phase-1 clinical trial of SUVN-I6107, for treating cognitive disorders Read more
Elucidation of part of the mechanism by which Lecanemab slows the progression of Alzheimer’s Read more
Indian pharma companies focus on innovative research in foreign countries through dedicated entities Read more
Dr Jitendra Singh chairs the 2nd Annual General Meeting of Biotechnology Research and Innovation Council Society Read more
